LumiGene Inks Reverse Acquisition Pact with Pole Perfect; Dances into Public Market | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – LumiGene today announced it has signed a letter of intent to be acquired by dance studio Pole Perfect Studios in a reverse acquisition that will take LumiGene public.

Upon completion of the deal, LumiGene will become the primary focus of the combined company.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."